Skip to content
  • Home
  • SeaPRwire
  • ACN Newswire
  • JCN Newswire
  • EQS Newswire
  • Latest News
  • Business
  • Finance
  • Contact Us

Search

  • Home
  • SeaPRwire
  • ACN
  • JCN
  • EQS
  • Contact
亚洲新闻、事件、深度報道

patients

ACN Newswire
Read More

Adlai Nortye Announces First Patient Dosed in Phase Ia Clinical Trial of AN2025 and AN0025 in Combination with atezolizumab for Advanced Solid Tumors

indie 8 September
6 minutes

NEW JERSEY, the U.S. and HANGZHOU, China, Sep 8, 2021 – (ACN Newswire via SEAPRWire.com) – Adlai Nortye, a global biopharmaceutical company focused on developing innovative oncology drugs, today announced […]

SeaPRwire
Read More

Quarantine for staff and patients of NKF dialysis centre with Covid-19 cluster

aseanpr 10 August
3 minutes

SINGAPORE – All front-line staff and some patients of the NKF Dialysis Centre (Sakyadhita) in Boon Keng have been placed on quarantine after it was announced on Monday (Aug 9) […]

SeaPRwire
Read More

Ward visitors at hospitals thin out as ban kicks in to stem Covid-19 transmission

aseanpr 5 August
3 minutes

SINGAPORE – Crowds were seen at several local hospitals, but most were there for outpatient treatment on Thursday (Aug 5), the first day of the barring of visits to hospital wards […]

JCN Newswire
Read More

Eisai’s Anti-Epileptic Drug Fycompa Approved In China As Monotherapy For Partial-Onset Seizures And Pediatric Indication For Partial-Onset Seizures

ruth 2 August
3 minutes

TOKYO, Aug 2, 2021 – (JCN Newswire via SEAPRWire.com) – Eisai Co., Ltd. announced today that its in-house discovered and developed anti-epileptic drug (AED) Fycompa (generic name: perampanel) has obtained […]

SeaPRwire

Singapore team finds drug cocktail effective against Covid-19 Delta variant

aseanpr 2 August
4 minutes

SINGAPORE – Researchers here have found a combination of drugs which can be used to treat Covid-19 patients with mild to moderate disease. The drug cocktail has also shown promising […]

JCN Newswire
Read More

Eisai: FDA Approves LENVIMA (lenvatinib) Plus KEYTRUDA (pembrolizumab) Combination for Patients With Certain Types of Advanced Endometrial Carcinoma

ruth 23 July
5 minutes

TOKYO and KENILWORTH, N.J., Jul 23, 2021 – (JCN Newswire via SEAPRWire.com) – Eisai Co., Ltd. and Merck & Co., Inc., Kenilworth, N.J., U.S.A. (known as MSD outside the United […]

JCN Newswire
Read More

Eisai Launchs Bile Acid Transporter Inhibitor Goofice in Thailand

ruth 19 July
2 minutes

TOKYO, Jul 19, 2021 – (JCN Newswire via SEAPRWire.com) – Eisai Co., Ltd. announced that its Thailand subsidiary Eisai (Thailand) Marketing Co., Ltd. has launched the bile acid transporter inhibitor […]

SeaPRwire
Read More

Regeneron Pharmaceutical’s Covid-19 antibody cocktail likely be used in Singapore once available

aseanpr 8 July
6 minutes

SINGAPORE – Regeneron Pharmaceutical’s Covid-19 antibody cocktail – which can be used to treat patients who are mildly sick but are at risk of severe illness – will likely be […]

ACN Newswire
Read More

ACT Genomics Completes Acquisition of MC Diagnostics

indie 6 July
4 minutes

HONG KONG, Jul 6, 2021 – (ACN Newswire via SEAPRWire.com) – ACT Genomics Co. Ltd. (“ACT Genomics” or “the Group”) has completed the acquisition of MC Diagnostics Ltd. (“MCD”), a […]

SeaPRwire
Read More

Morning Briefing: Top stories from The Straits Times on June 9, 2021

aseanpr 9 June
2 minutes

Good morning! Here are our top stories to kick-start your Wednesday, June 9. 86-year-old linked to TTSH Covid-19 cluster dies; Four Leaves staff among unlinked cases The woman’s husband had been […]

JCN Newswire
Read More

Biogen and Eisai launch initiatives to help patients with Alzheimer’s disease access ADUHELM

ruth 8 June
7 minutes

Cambridge, MA, Jun 8, 2021 – (JCN Newswire via SEAPRWire.com) – Following U.S. Food and Drug Administration’s (FDA) accelerated approval of ADUHELMTM (aducanumab-avwa) as the first and only Alzheimer’s disease […]

JCN Newswire
Read More

FDA grants accelerated approval for ADUHELM as the first and only Alzheimer’s disease treatment to address a defining pathology of the disease

ruth 8 June
4 minutes

TOKYO, Jun 8, 2021 – (JCN Newswire via SEAPRWire.com) – Biogen (Nasdaq: BIIB) and Eisai, Co., Ltd. (Tokyo, Japan) today announced that the U.S. Food and Drug Administration (FDA) has […]

JCN Newswire
Read More

Eisai to Present Data on Oncology Pipeline and Products at ASCO Annual Meeting

ruth 20 May
3 minutes

TOKYO, May 20, 2021 – (JCN Newswire via SEAPRWire.com) – Eisai Co., Ltd. announced today that the latest data regarding its oncology pipeline and products including in-house discovered lenvatinib mesylate […]

JCN Newswire
Read More

Anticancer Agent “Remitoro Intravenous Drip Infusion 300 microgram” (Denileukin Diftitox (Genetical Recombination)) Launched in Japan

ruth 19 May
3 minutes

Tokyo, May 19, 2021 – (JCN Newswire via SEAPRWire.com) – Eisai Co., Ltd. announced today that it has launched the anticancer agent “Remitoro® for Intravenous Drip Infusion 300μg” (Denileukin Diftitox […]

SeaPRwire
Read More

Surge in A&E patients at SGH and Sengkang General Hospital, SKH wards operating at full capacity

aseanpr 1 May
3 minutes

SINGAPORE – Both Singapore General Hospital (SGH) and Sengkang General Hospital (SKH) have reported a high number of patients at their emergency departments. SKH has said its wards are now […]

SeaPRwire

How Mount Alvernia keeps its patients’ bills low

elean 25 April
1 minute

SINGAPORE – Mount Alvernia Hospital has consistently been praised by insurers for charging the lowest among all private hospitals here because it does not see itself as a profit centre. […]

ACN Newswire
Read More

Hua Medicine Announces Acceptance of a New Drug Application for Dorzagliatin in China – First Glucokinase Activator (GKA) Globally

indie 23 April
7 minutes

SHANGHAI, CHINA, Apr 23, 2021 – (ACN Newswire via SEAPRWire.com) – Hua Medicine (the “Company”, Stock Code: 2552.HK), today announced that the New Drug Application (NDA) for dorzagliatin for the […]

JCN Newswire
Read More

Eisai: Gilead Sciences Submits New Drug Application in Japan for Filgotinib for the Treatment of Ulcerative Colitis with an Inadequate Response to Conventional Therapies

ruth 23 April
4 minutes

TOKYO, Apr 23, 2021 – (JCN Newswire via SEAPRWire.com) – Gilead Sciences K.K. and Eisai Co., Ltd. today announced that Gilead submitted an application to Japan’s Pharmaceuticals and Medical Devices […]

SeaPRwire
Read More

Me & My Career: She left comfort zone in banking to pursue passion in nursing

elean 11 April
9 minutes

SINGAPORE – The death of a friend in 2014 was not just a stark reminder to Ms Vivian Leong Wan Yee that life is short, it also pushed her to […]

ACN Newswire
Read More

China Medical System (0867.HK): Accelerating Development and Stepping to a New Height Driven by Innovation

indie 3 April
16 minutes

HONG KONG, Apr 2, 2021 – (ACN Newswire via SEAPRWire.com) – As the earning season approaches, once again listed pharmaceutical companies are attracting the attention of the public. Recently, China […]

Previous 1 2 3 4 Next

Links

  • YAHOO
  • NASDAQ
  • Bloomberg
  • Newswire
  • EastMud
  • AsiaEase
  • NetDace
  • PostVN
  • VOASG
  • EventPH
September 2025
M T W T F S S
1234567
891011121314
15161718192021
22232425262728
2930  
« Aug    

网站导航

  • Home
  • Latest News
  • Business
  • Finance
  • SeaPRwire
  • ACN Newswire
  • JCN Newswire
  • EQS Newswire
  • Contact Us

Search

  • Home
  • Latest News
  • Business
  • Finance
  • SeaPRwire
  • ACN Newswire
  • JCN Newswire
  • EQS Newswire
  • Contact Us
Copyright © 2020 ASEANPR.Com All rights reserved.